Early [Beta]-Blocker Therapy for Acute Myocardial Infarction in Elderly Patients

Article Abstract:

Increasing the early use of Beta-blockers for patients who were hospitalized with an acute myocardial infarction would provide an excellent opportunity to improve their care and outcomes. Of 58,165 patients, 28,256 (49%) received early Beta-blocker therapy, but the 51% of patients who were at highest for in-hospital death were the least likely to receive therapy. Patients who received Beta-blockers had a lower in-hospital mortality rate than patients who did not receive Beta-blockers even after adjustment for differences. The early use of Beta-blockers should be increased for these patients to improve their care and outcomes.

Prognosis, Adrenergic beta blockers, Adrenergic beta-antagonists

---

Thrombolytic therapy for eligible elderly patients with acute myocardial infarction

Article Abstract:

Many elderly heart attack patients are not receiving thrombolytic therapy even though they might benefit from it. Thrombolytic drugs break up the blood clots that cause most heart attacks. Researchers analyzed Medicare data on 3,093 patients treated for a heart attack. Of the 753 patients who had no contraindications for thrombolytic therapy, over half did not receive it. Those who were older, had no chest pain and who were hospitalized more than 6 hours after their symptoms began were most likely not to receive thrombolytic therapy.

Aged, Elderly, Usage, Drug therapy, Thrombolytic therapy

---

Similar abstracts:

• Abstracts: New NICE guidance on the secondary prevention of MI. Guidance on treating urinary tract infection in children
• Abstracts: The primary prevention of coronary heart disease in women. Adjunctive drug therapy of acute myocardial infarction - evidence from clinical trials
• Abstracts: Passive smoking and impaired endothelium-dependent arterial dilatation in healthy young adults. Differences in the effect of cigarette smoking on endothelial function in Chinese and white adults
• Abstracts: Group A streptococcal infections and acute rheumatic fever. Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A
• Abstracts: Quality group to form physician advisory panel. Nine Blues plans sign on to uniform medical policies

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.